NCT00658047View on ClinicalTrials.gov

A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

June 30, 2009

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

CH-1504

Comparison of different doses of CH-1504

DRUG

Methotrexate (MTX)

10mg/week for 2 weeks escalated to 15mg/week for 2 weeks escalated to 20mg/week for 8 weeks

Trial Locations (1)

M5G 1X5

The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Toronto

Sponsors
All Listed Sponsors
lead

Chelsea Therapeutics

INDUSTRY